Jim Simons Lucid Diagnostics Inc. Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 459,065 shares of LUCD stock, worth $523,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
459,065Holding current value
$523,334% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding LUCD
# of Institutions
49Shares Held
9.45MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA2.73MShares$3.11 Million0.21% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL1.89MShares$2.15 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA889KShares$1.01 Million0.0% of portfolio
-
Luminus Management LLC Houston, TX457KShares$520,5740.62% of portfolio
-
Ghisallo Capital Management LLC Greenwich, CT422KShares$481,0840.24% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $44M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...